SWA
CVS icon

SFMG Wealth Advisors’s CVS Health CVS Stock Holding History

SFMG Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18,402
Closed -$1.28M – 277
2023
Q3 		$1.28M Buy
18,402
+12
+0.1% +$850 0.13% 77
2023
Q2 		$1.27M Sell
18,390
-162
-0.9% -$11.5K 0.13% 80
2023
Q1 		$1.38M Sell
18,552
-126
-0.7% -$10.6K 0.15% 74
2022
Q4 		$1.74M Buy
18,678
+5
+0% +$482 0.19% 69
2022
Q3 		$1.64M Buy
18,673
+2,443
+15% +$242K 0.19% 65
2022
Q2 		$1.5M Sell
16,230
-443
-3% -$43.2K 0.17% 72
2022
Q1 		$1.69M Sell
16,673
-13,837
-45% -$1.45M 0.17% 74
2021
Q4 		$3.15M Sell
30,510
-665
-2% -$61.5K 0.31% 45
2021
Q3 		$2.65M Sell
31,175
-718
-2% -$60.1K 0.29% 48
2021
Q2 		$2.66M Sell
31,893
-335
-1% -$27.4K 0.3% 42
2021
Q1 		$2.42M Sell
32,228
-189
-0.6% -$13.8K 0.28% 46
2020
Q4 		$2.21M Sell
32,417
-601
-2% -$39.1K 0.28% 45
2020
Q3 		$1.93M Buy
33,018
+28,951
+712% +$1.8M 0.27% 41
2020
Q2 		$264K Sell
4,067
-7,535
-65% -$474K 0.04% 131
2020
Q1 		$688K Buy
+11,602
New +$775K 0.1% 57
2018
Q1 		– Sell
-2,800
Closed -$203K – 160
2017
Q4 		$203K Buy
2,800
+2
+0.1% +$145 0.03% 135
2017
Q3 		$228K Buy
2,798
+43
+2% +$3.4K 0.04% 117
2017
Q2 		$222K Sell
2,755
-185
-6% -$14.6K 0.05% 112
2017
Q1 		$231K Buy
2,940
+199
+7% +$15.9K 0.05% 107
2016
Q4 		$216K Sell
2,741
-85
-3% -$6.88K 0.05% 108
2016
Q3 		$251K Hold
2,826
– – 0.06% 91
2016
Q2 		$271K Buy
2,826
+25
+0.9% +$2.49K 0.06% 89
2016
Q1 		$291K Buy
2,801
+60
+2% +$5.83K 0.06% 81
2015
Q4 		$268K Hold
2,741
– – 0.06% 93
2015
Q3 		$264K Buy
2,741
+300
+12% +$31.5K 0.06% 90
2015
Q2 		$256K Hold
2,441
– – 0.06% 91
2015
Q1 		$252K Buy
2,441
+200
+9% +$20.2K 0.02% 152
2014
Q4 		$216K Buy
+2,241
New +$197K 0.05% 110

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SFMG Wealth Advisors's CVS Position: Q4 2023 in Review

SFMG Wealth Advisors sold out of CVS Health (CVS) in Q4 2023, closing a stake of 18,402 shares — an estimated $1.28M sold.

SFMG Wealth Advisors first reported a position in CVS in Q4 2014 and held it in 28 quarters. The position peaked at $3.15M in Q4 2021. 2,258 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • SFMG Wealth Advisors reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • SFMG Wealth Advisors sold 18,402 CVS Health shares in Q4 2023, an estimated $1.28M.
  • SFMG Wealth Advisors first reported a position in CVS Health in Q4 2014 and held it in 28 quarters.
  • SFMG Wealth Advisors's CVS Health position peaked at $3.15M in Q4 2021.
  • 2,258 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on SFMG Wealth Advisors's 13F filing for Q4 2023, filed 30 Jan 2024.